Bristol Myers Squibb (NYSE: BMY) today announced that the company will hold a Research & Development (R&D) Day in New York City on Thursday, September 14, 2023, at 9:00 a.m. Company executives will provide investors and analysts with an overview of the company’s R&D strategy and pipeline opportunities.
The event will be simultaneously webcast at http://investor.bms.com, with materials related to the presentation available at the start of the live webcast. A replay and archived edition of the presentation will be available following the event.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20230531005241/en/
Contacts
For more information, contact:
Media:
media@bms.com
Investors:
investor.relations@bms.com
